Nowtransit Inc
BioScience Health Innovations, Inc. distributes clinically tested and affordably priced products to battle the onslaught of bacteria and viruses. The company markets Be On-Guard Mouth Spray and Nasal Spray; EZ Safer Surface Cleaner; Be On-Guard brain fog support; Active Daily Health Defence 365 for maximum strength brain support; NeuroPro Plus, a patent pending combination of pharmaceutical grade… Read more
Nowtransit Inc (NOTR) - Total Liabilities
Latest total liabilities as of March 2025: $132.92K USD
Based on the latest financial reports, Nowtransit Inc (NOTR) has total liabilities worth $132.92K USD as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Nowtransit Inc - Total Liabilities Trend (2019–2024)
This chart illustrates how Nowtransit Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Nowtransit Inc Competitors by Total Liabilities
The table below lists competitors of Nowtransit Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
China Reform Culture Holdings Co Ltd
SHG:600636
|
China | CN¥118.95 Million |
|
Sinolong New Materials Co., Ltd.
SHE:301565
|
China | CN¥1.41 Billion |
|
Artesian Resources Corporation
NASDAQ:ARTNA
|
USA | $585.07 Million |
|
Ningxia Younglight Chemicals Co Ltd
SHE:000635
|
China | CN¥1.45 Billion |
|
FastPartner AB Series D
ST:FPAR-D
|
Sweden | Skr21.51 Billion |
|
GMR Power and Urban Infra Limited
NSE:GMRP&UI
|
India | ₹150.30 Billion |
|
AGARWALEYE
NSE:AGARWALEYE
|
India | ₹17.67 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Nowtransit Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 10.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nowtransit Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nowtransit Inc (2019–2024)
The table below shows the annual total liabilities of Nowtransit Inc from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $38.55K | -61.51% |
| 2023-12-31 | $100.15K | +5284.30% |
| 2022-12-31 | $1.86K | -90.26% |
| 2021-12-31 | $19.11K | +144.60% |
| 2020-12-31 | $7.81K | -511.11% |
| 2019-12-31 | $-1.90K | -- |